From Casetext: Smarter Legal Research

Merck Sharp & Dohme Corp. v. Mylan Pharms. Inc.

United States Court of Appeals for the Federal Circuit
Feb 7, 2013
496 F. App'x 87 (Fed. Cir. 2013)

Opinion

2012-1434

02-07-2013

MERCK SHARP & DOHME CORP., MSD INTERNATIONAL GMBH, Plaintiffs-Appellees, v. MYLAN PHARMACEUTICALS INC., Defendant-Appellant.

DAVID T. PRITIKIN, Sidley Austin, LLP, of Chicago, Illinois, argued for plaintiffs-appellees. With him on the brief were WILLIAM H. BAUMGARTNER, JR. and CONSTANTINE L. TRELA, JR.; and PETER S. CHOI, of Washington, DC; and TODD L. KRAUSE, of New York, New York. Of counsel on the brief were PAUL D. MATUKAITIS, EDWARD W. MURRAY and LISA A. JAKOB, Merck & Co., Inc., of Rahway, New Jersey. Of counsel was DONALD A. ROBINSON, Robinson, Wettre & Miller LLC, of Newark, New Jersey. THOMAS J. PARKER, Alston & Bird, LLP, of New York, New York, argued for defendant-appellant. Of counsel were BLAS P. ARROYO and JITENDRA MALIK, of Charlotte, North Carolina; and DEEPRO MUKERJEE, of New York, New York.


NOTE: This disposition is nonprecedential.


Appeal from the United States District Court for the District of New Jersey in No. 10-CV-3085, Judge Jose L. Linares.

JUDGMENT

DAVID T. PRITIKIN, Sidley Austin, LLP, of Chicago, Illinois, argued for plaintiffs-appellees. With him on the brief were WILLIAM H. BAUMGARTNER, JR. and CONSTANTINE L. TRELA, JR.; and PETER S. CHOI, of Washington, DC; and TODD L. KRAUSE, of New York, New York. Of counsel on the brief were PAUL D. MATUKAITIS, EDWARD W. MURRAY and LISA A. JAKOB, Merck & Co., Inc., of Rahway, New Jersey. Of counsel was DONALD A. ROBINSON, Robinson, Wettre & Miller LLC, of Newark, New Jersey.

THOMAS J. PARKER, Alston & Bird, LLP, of New York, New York, argued for defendant-appellant. Of counsel were BLAS P. ARROYO and JITENDRA MALIK, of Charlotte, North Carolina; and DEEPRO MUKERJEE, of New York, New York. THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (DYK, MAYER, and REYNA, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

______________

Jan Horbaly

Clerk


Summaries of

Merck Sharp & Dohme Corp. v. Mylan Pharms. Inc.

United States Court of Appeals for the Federal Circuit
Feb 7, 2013
496 F. App'x 87 (Fed. Cir. 2013)
Case details for

Merck Sharp & Dohme Corp. v. Mylan Pharms. Inc.

Case Details

Full title:MERCK SHARP & DOHME CORP., MSD INTERNATIONAL GMBH, Plaintiffs-Appellees…

Court:United States Court of Appeals for the Federal Circuit

Date published: Feb 7, 2013

Citations

496 F. App'x 87 (Fed. Cir. 2013)

Citing Cases

In re Zetia (Ezetimibe) Antitrust Litig.

This decision was subsequently affirmed by the Federal Circuit. See Merck, Sharp & Dohme Corp. v. Mylan…

In re Zetia (Ezetimibe) Antitrust Litig.

This decision was subsequently affirmed by the Federal Circuit. See Merck, Sharp & Dohme Corp, v. Mylan…